THE GENETIC-POLYMORPHISM OF SPARTEINE METABOLISM

被引：88
作者：
EICHELBAUM, M [1 ]
REETZ, KP [1 ]
SCHMIDT, EK [1 ]
ZEKORN, C [1 ]
机构：
[1] UNIV BONN,MED KLIN,D-5300 BONN,FED REP GER
来源：
XENOBIOTICA | 1986年 / 16卷 / 05期
关键词：
D O I：
10.3109/00498258609050252
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：465 / 481
页数：17
相关论文
共 45 条
  • [1] BAUR M, 1984, EUR J CLIN PHARM, V27, P255
  • [2] BERNASCONI R, 1965, PHARM ACTA HELV, V40, P275
  • [3] PHARMACOGENETIC COVARIATION OF DEFECTIVE N-OXIDATION OF SPARTEINE AND 4-HYDROXYLATION OF DEBRISOQUINE
    BERTILSSON, L
    DENGLER, HJ
    EICHELBAUM, M
    SCHULZ, HU
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (02) : 153 - 155
  • [4] FURTHER-STUDIES ON CHEMISTRY AND STRUCTURE OF N-OXIDES OF SPARTEINE AND ITS DERIVATIVES .5. SYNTHESIS AND STRUCTURE OF 2-PHENYLSPARTEINE-N16-OXIDE, A NEW CASE OF SPONGE PROTON
    BOCZON, W
    PIECZONKA, G
    WIEWIOROWSKI, M
    [J]. TETRAHEDRON, 1977, 33 (19) : 2565 - 2570
  • [5] BOHLMANN F, 1967, ALKALOIDS CHEMISTRY, V9, P175
  • [6] BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
  • [7] BRAZEAU P, 1965, PHARMACOL BASIS THER, P886
  • [8] ADVERSE-EFFECTS FROM METOPROLOL ARE NOT GENERALLY ASSOCIATED WITH OXIDATION STATUS
    CLARK, DWJ
    MORGAN, AKW
    WAALMANNING, H
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 18 (06) : 965 - 967
  • [9] Cook A. G., 1969, ENAMINES SYNTHESIS S
  • [10] THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM
    DAHLQVIST, R
    BERTILSSON, L
    BIRKETT, DJ
    EICHELBAUM, M
    SAWE, J
    SJOQVIST, F
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) : 815 - 821
12345